In the BioHarmony Drug Report Database

"Preview" Icon

Sofosbuvir

Sovaldi (sofosbuvir) is a small molecule pharmaceutical. Sofosbuvir was first approved as Sovaldi on 2013-12-06. It is used to treat chronic hepatitis c and hepatitis c in the USA. It has been approved in Europe to treat chronic hepatitis c. Sovaldi’s patents are valid until 2030-12-11 (FDA).

 

Trade Name

 

Sovaldi
 

Common Name

 

sofosbuvir
 

ChEMBL ID

 

CHEMBL1259059
 

Indication

 

chronic hepatitis c, hepatitis c
 

Drug Class

 

Phosphoro-derivatives; antivirals: RNA polymerase (NS5B) inhibitor

Image (chem structure or protein)

Sofosbuvir structure rendering